INTERNATIONAL PATENT: THE CHINESE UNIVERSITY OF HONG KONG FILES APPLICATION FOR "USE OF RECOMBINANT PHAGE IN CANCER THERAPY"

GENEVA, Dec. 8 -- THE CHINESE UNIVERSITY OF HONG KONG (Office of Research and Knowledge Transfer Services, Room 301, Pi Ch'iu Building, Shatin, New TerritoriesHong Kong) filed a patent application (PCT/CN2025/095285) for "USE OF RECOMBINANT PHAGE IN CANCER THERAPY" on May 16, 2025. With publication no. WO/2025/246968, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MAO, Chuanbin (Department of Biomedical Engineering, The Chinese University of Hong Kong, Shatin, New TerritoriesHong Kong)

Abstract: This disclosure relates ...